Development of Differentiation-directed Cancer Gene Therapy with p21

p21 分化导向癌症基因治疗的发展

基本信息

  • 批准号:
    09671310
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

A cycline-dependent kinase inhibitor p21 is induced in thc process of differentiation. To develop a novel gene-based anti-cancer therapy that can induce a welI-differentiated state in cancer cells, we examined antitumor offeet of the p21 gene transfer on human cancer cells. A recombinant adenovirus-mediated transient overexpression of p21 on TE-1 human esophageal cancer cells exhibited morphological changes indicative of differentiation, such as enlarged nuclei and flattened shape. Moreover, expression of involucrin protein, a differentiation marker of squamous cells, was up-regulated after the p21 gene transfer. We also found that retinoic acid receptor (RAR) was positively regulated by the p21 gene transfer in DLD-1 (colon), 1-11299 (lung), H460 (lung), and TE-13 (esophagus) human cancer cell lines. Increased expression of RAR induced the sensitivity to retinoic acid (RA) in RA-resistant DLD-1 cancer cells, resulting in the synergistic antitumor effect of the p21 gene transfer and RA treatment. These observations suggest that adenovirus-mediated p21 gene transfer can induce differentiation in human cancer cells and that the p21 gene has important implications for a differentiation-directed molecular therapy.
细胞周期依赖性激酶抑制剂p21在分化过程中被诱导。为了开发一种新的基于基因的抗癌治疗方法,可以诱导癌细胞的良好分化状态,我们研究了p21基因转移对人癌细胞的抗肿瘤效应。重组腺病毒介导的p21在TE-1人食管癌细胞上的瞬时过表达表现出指示分化的形态学变化,例如核增大和扁平形状。此外,p21基因转染后,鳞状细胞分化标志物外皮蛋白的表达上调。我们还发现,视黄酸受体(RAR)的正调控的p21基因转移在DLD-1(结肠),1-11299(肺),H460(肺),TE-13(食管)人癌细胞系。RAR的表达增加诱导RA耐药的DLD-1癌细胞对维甲酸(RA)的敏感性,导致p21基因转移和RA治疗的协同抗肿瘤作用。这些观察结果表明,腺病毒介导的p21基因转移可以诱导人类癌细胞的分化,p21基因具有重要意义的分化导向的分子治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kagawa S, Fujiwara T, Hizuta A, Yasuda T, et al: "p53 expression overcomes p21^<AF1/CIP1>-mediated G1 arrest and induces apoptosis in human cancer cells" Oncogene. 15. 1903-1910 (1997)
Kakawa S、Fujiwara T、Hizuta A、Yasuda T 等人:“p53 表达克服了 p21^<AF1/CIP1> 介导的 G1 停滞并诱导人类癌细胞凋亡”Oncogene。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIZUTA Akio其他文献

HIZUTA Akio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIZUTA Akio', 18)}}的其他基金

Gene Therapy for Colon Cancer with Adenoviral Vector Expressing Tumor Suppressor p53 Gene
表达肿瘤抑制p53基因的腺病毒载体对结肠癌的基因治疗
  • 批准号:
    07671393
  • 财政年份:
    1995
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Induction of cytotoxicity of human tumor-infiltrating lymphocytes against autologous tumor cells and its application for cancer therapy
人肿瘤浸润淋巴细胞对自体肿瘤细胞的细胞毒性诱导及其在癌症治疗中的应用
  • 批准号:
    63570599
  • 财政年份:
    1988
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
  • 批准号:
    BB/Y003454/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Fellowship
感情制御を妨害するemotion differentiationの心理生理学的メカニズムの解明
阐明干扰情绪调节的情绪分化的心理生理机制
  • 批准号:
    24K00493
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
tRNA biology in healthy ageing: Functional differentiation and expression of tRNAiMet loci in Drosophila.
健康老龄化中的 tRNA 生物学:果蝇中 tRNAiMet 位点的功能分化和表达。
  • 批准号:
    BB/Y000919/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
CAREER: Functional genomic architecture and population differentiation of a polygenic and sexually dimorphic butterfly mimicry phenotype
职业:多基因和性二态性蝴蝶拟态表型的功能基因组结构和群体分化
  • 批准号:
    2340675
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Continuing Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Excellence in Research: Developmental regulation of WDR77 coordinates prostate growth and differentiation during the development through puberty
卓越研究:WDR77 的发育调节可协调青春期发育期间的前列腺生长和分化
  • 批准号:
    2300390
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Standard Grant
Comparative single-cell analysis of disease-derived stem cells to identify the cell fate defect on the cell differentiation trajectory
对疾病来源的干细胞进行比较单细胞分析,以确定细胞分化轨迹上的细胞命运缺陷
  • 批准号:
    23H02466
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Permissive differentiation and functional regulation of macrophages through TREM2
通过 TREM2 允许巨噬细胞分化和功能调节
  • 批准号:
    23H02738
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Comprehensive analysis of the differentiation and function of neoantigen-specific T cells
新抗原特异性T细胞的分化和功能综合分析
  • 批准号:
    23H02762
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了